bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.12.23.630188

Crossover model of Lep-Rec reveals higher heritability of recombination

Rastas, P. M. A.·Kivioja, T.
View original source ↗Export metadata ↓

Abstract

Meiotic recombination, a process that reshuffles DNA between parental chromosomes, is almost universal in multicellular organisms. Recombination accelerates the response to selection by breaking the linkage and creating new allelic combinations that can affect the fitness of the progeny. This motivates us to characterise recombination rate variation and to take it into account in evolutionary models and studies. Linkage mapping utilises recombination to obtain recombination distances for genetic markers. With (whole) genome sequencing data, very dense linkage maps can be produced, locating crossovers precisely in the genome. This enables direct and accurate calculation of recombination distances, correction of possible errors in the genome and maps, and studying the relation between recombination and physical base-pair distances. This is now a relevant problem, as high-quality genomes are emerging for many species, and available dense linkage map data would supplement these genomes. Here we present a novel software Lep-Rec to compute the local re-combination rate, i.e. the percentage of crossovers per individual per megabase (cM/Mb) along the genome. Moreover, it can also estimate the underlying, only partly observed, tetrad crossover distribution for each chromosome, while modelling crossover and chromatid interference. Together with Lep-MAP3 and Lep-Anchor, Lep-Rec forms a complete toolbox for studying recombination and crossovers: Lep-MAP3 can robustly construct linkage maps for large number of markers and individuals, while Lep-Anchor can anchor, validate and correct genome assemblies using linkage maps, and together these software provide consistent and complete physical and linkage maps for further analysis with Lep-Rec. Lep-Rec is available from http://sourceforge.net/projects/lep-anchor. Finally, we demonstrate the performance of Lep-Rec using real and simulated data: It outperforms and simplifies currently available tools and its estimated crossover distribution can improve association analysis and heritability estimates of recombination.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Rastas, P. M. A., Kivioja, T.. 2024-12-24. Crossover model of Lep-Rec reveals higher heritability of recombination. https://doi.org/10.1101/2024.12.23.630188

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗
bioRxiv2026

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗
bioRxiv2026

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗